|
MRPL55 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.022200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.074640E-01 |
| Normal-vs-Stage2 |
1.150000E-01 |
| Normal-vs-Stage3 |
1.004950E-01 |
| Normal-vs-Stage4 |
3.534000E-01 |
| Stage1-vs-Stage2 |
4.459700E-02 |
| Stage1-vs-Stage3 |
3.240000E-01 |
| Stage1-vs-Stage4 |
8.091800E-01 |
| Stage2-vs-Stage3 |
1.912470E-02 |
| Stage2-vs-Stage4 |
8.658000E-02 |
| Stage3-vs-Stage4 |
2.965600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.578200E-02 |
| Normal-vs-AfricanAmerican |
8.718200E-01 |
| Normal-vs-Asian |
7.484800E-01 |
| Caucasian-vs-AfricanAmerican |
3.157600E-01 |
| Caucasian-vs-Asian |
7.760800E-01 |
| AfricanAmerican-vs-Asian |
9.417600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.655600E-01 |
| Normal-vs-Female |
5.971400E-01 |
| Male-vs-Female |
7.647600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.358960E-01 |
| Normal-vs-Extreme_Weight |
6.959900E-02 |
| Normal-vs-Obese |
2.908000E-01 |
| Normal-vs-Extreme_Obese |
6.590600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.029200E-01 |
| Normal_Weight-vs-Obese |
6.970400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.634000E-01 |
| Extreme_Weight-vs-Obese |
8.083200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.022600E-01 |
| Obese-vs-Extreme_Obese |
8.652800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.663000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.007600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.434000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.817810E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.251000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.016200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.471190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.990600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.697650E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.181900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.730200E-01 |
| Normal-VS-Type2 PRCC |
3.687600E-02 |
| Normal-VS-KIRP CIMP |
5.282100E-03 |
| Normal-VS-Unclassified PRCC |
9.214200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.409240E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.487500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.357800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.179000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.287790E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.925900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.409700E-02 |
| Normal-vs-N1 |
4.275200E-01 |
| Normal-vs-N2 |
8.348100E-02 |
| N0-vs-N1 |
5.704600E-01 |
| N0-vs-N2 |
7.380600E-01 |
| N1-vs-N2 |
3.359600E-01 |
|
|
